Study shows weight regain after stopping Eli Lilly's Zepbound

Latest Company News - Finance News Network

English - December 11, 2023 20:27 - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Costa faces earnings downgrade, Paine Schwartz eyes lower offer price

Next Episode: Gold's rapid descent: From record highs to uncertain lows in a week

12 Dec 2023 - In a significant development, new data indicates that patients who underwent treatment with Eli Lilly's groundbreaking weight loss drug, Zepbound, faced weight regain after discontinuing the medication for a year.